SCI时时刷

search
Social determinants of health and cancer mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study
Social determinants of health and cancer mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study
Background Social determinants of health (SDOHs) cluster together and can have deleterious impacts on health outcomes. Ind...
Peripheral blood parameter abnormalities precede therapy‐related myeloid neoplasms after autologous transplantation for lymphoma
Peripheral blood parameter abnormalities precede therapy‐related myeloid neoplasms after autologous transplantation for lymphoma
Background Therapy-related myeloid neoplasms (t-MN) are a leading cause of nonrelapse mortality after autologous periphera...
Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial
Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial
Background The value of neoadjuvant chemotherapy in soft tissue sarcoma (STS) is not completely understood. This study inv...
Cerebrospinal fluid flow cytometry and risk of central nervous system relapse after hyperCVAD in adults with acute lymphoblastic leukemia
Cerebrospinal fluid flow cytometry and risk of central nervous system relapse after hyperCVAD in adults with acute lymphoblastic leukemia
Background Potential involvement of the central nervous system (CNS) by acute lymphoblastic leukemia is typically evaluate...
Dietary supplement use by individuals living with and beyond breast, prostate, and colorectal cancer: A cross‐sectional survey
Dietary supplement use by individuals living with and beyond breast, prostate, and colorectal cancer: A cross‐sectional survey
Background Dietary supplements (DSs) are not recommended for the prevention of cancer recurrence. Although DS use is commo...
JASPER: Phase 2 trial of first‐line niraparib plus pembrolizumab in patients with advanced non–small cell lung cancer
JASPER: Phase 2 trial of first‐line niraparib plus pembrolizumab in patients with advanced non–small cell lung cancer
Background Poly(ADP-ribose) polymerase (PARP) inhibitors may synergize with programmed cell death receptor-1 (PD-1) inhibi...
First Person Profile: Melissa M. Hudson, MD
First Person Profile: Melissa M. Hudson, MD
Melissa M. Hudson, MD, director of the Division of Cancer Survivorship at St. Jude Children's Research Hospital, recalls t...
The Survivorship Sleep Program (SSP): A synchronous, virtual cognitive behavioral therapy for insomnia pilot program among cancer survivors
The Survivorship Sleep Program (SSP): A synchronous, virtual cognitive behavioral therapy for insomnia pilot program among cancer survivors
Background For cancer survivors, insomnia is prevalent, distressing, and persists for years if unmanaged. Cognitive behavi...
Cancer case trends following the onset of the COVID‐19 pandemic: A community‐based observational study with extended follow‐up
Cancer case trends following the onset of the COVID‐19 pandemic: A community‐based observational study with extended follow‐up
Background The coronavirus disease 2019 (COVID-19) pandemic has impacted health care delivery worldwide. Cancer is a leadi...
Increasing referral of at‐risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center
Increasing referral of at‐risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center
Background Genetic evaluation and testing for hereditary breast and ovarian cancer (HBOC) remain suboptimal. The authors e...
Update to new oncology medical home standards
Update to new oncology medical home standards
The American Society of Clinical Oncology (ASCO) and the Community Oncology Alliance (COA) have jointly released new Oncol...
Recent studies show that women in oncology face gender harassment, wage gaps
Recent studies show that women in oncology face gender harassment, wage gaps
Women in medicine continue to face gender biases and an existing wage gap in the workplace. Overcoming these gender-based ...
Knowledge and distress in complex cancer care
Knowledge and distress in complex cancer care
Web-based education enhances understanding of complex tumor genomic information, but this does not decrease distress in ge...
A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG‐ACRIN Cancer Research Group (EAQ152)
A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG‐ACRIN Cancer Research Group (EAQ152)
Background Enthusiasm for precision oncology may obscure the psychosocial and ethical considerations associated with the i...
First person profile: Norman E. “Ned” Sharpless, MD
First person profile: Norman E. “Ned” Sharpless, MD
Volume 127, Issue 24 p. 4529-4530 CancerScope As director of the National Cancer Institute, Dr. Sharpless ha...
Where it all began
Where it all began
In this powerful piece reproduced from Cancer's archives, Benno Schmidt, Sr, outlines the rationale for the National Cance...
The National Cancer Act of 1971: A seminal milestone in the fight against cancer
The National Cancer Act of 1971: A seminal milestone in the fight against cancer
The 1971 National Cancer Act paved the way for a collective national approach to improve outcomes for patients with cancer...
Mismatch repair and clinical response to immune checkpoint inhibitors in endometrial cancer
Mismatch repair and clinical response to immune checkpoint inhibitors in endometrial cancer
Lay Summary Endometrial cancer is common, and a subset recurs and requires additional treatment. Some of these are recogni...
A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability
A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability
Background Microsatellite instability–high (MSI-H)/mismatch repair deficiency (dMMR) is a biomarker for responses t...